Cargando…

Intravitreal bevacizumab

Detalles Bibliográficos
Autor principal:	Khamar, Bakulesh M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778565/ https://www.ncbi.nlm.nih.gov/pubmed/29283157 http://dx.doi.org/10.4103/ijo.IJO_802_17

Ejemplares similares

Severe epistaxis related to intravitreal bevacizumab
por: Otten, Leila S., et al.
Publicado: (2019)

Contaminated groundwater and acute postcataract Pseudomonas aeruginosa endophthalmitis
por: Mansuri, Mariam, et al.
Publicado: (2019)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus
por: Joob, Beuy, et al.
Publicado: (2017)

Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy
por: Shaikh, Saad
Publicado: (2008)

Diabetic papillopathy with macular edema treated with intravitreal bevacizumab
por: Al-Hinai, Ahmed S.
Publicado: (2012)

Treatment of polypoidal choroidal vasculopathy with intravitreal bevacizumab monotherapy
por: Tan, Colin S H, et al.
Publicado: (2013)

Paralytic ileus after bilateral intravitreal injection of bevacizumab
por: Kim, Young Gyun, et al.
Publicado: (2016)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Samanta, Ramanuj
Publicado: (2019)

Comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Tripathy, Koushik, et al.
Publicado: (2019)

Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy
por: Mandal, Subrata, et al.
Publicado: (2011)

Intravitreal bevacizumab for parafoveal telangiectasia-associated choroidal neovascular membrane
por: Shanmugam, Mahesh P, et al.
Publicado: (2007)

Intravitreal bevacizumab monotherapy for treatment-naive polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2014)

Intravitreal bevacizumab monotherapy for treatment-naïve polypoidal choroidal vasculopathy
por: Chhablani, Jay Kumar, et al.
Publicado: (2013)

Response to comment on: Dramatic response to intravitreal bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Response to comment on: Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy
por: Padhi, Srikant, et al.
Publicado: (2019)

Early Experience with Intravitreal Bevacizumab Combined with Laser Treatment for Retinopathy of Prematurity
por: Raizada, Seemant, et al.
Publicado: (2011)

Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
por: Mandal, Subrata, et al.
Publicado: (2011)

Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: Is there an association?
por: Bodla, Ali A, et al.
Publicado: (2010)

Pneumatic displacement and intravitreal bevacizumab for management of submacular hemorrhage in choroidal neovascular membrane
por: Agarwal, Manisha, et al.
Publicado: (2010)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Analyzing the role of intravitreal bevacizumab and pars plana vitrectomy in nontractional refractory diabetic macular edema
por: Dubey, Arvind Kumar, et al.
Publicado: (2016)

Decompression retinopathy after intravitreal bevacizumab and anterior chamber paracentesis in a patient with neovascular glaucoma
por: Kim, Eung Suk, et al.
Publicado: (2016)

Comment on: An unusual presentation of nonarteritic ischemic optic neuropathy with subretinal fluid treated with intravitreal bevacizumab
por: Kalamkar, Charudutt, et al.
Publicado: (2016)

Retinal pigment epithelial tear after intravitreal bevacizumab injection for exudative age-related macular degeneration
por: Singh, Sunil Kumar, et al.
Publicado: (2014)

Off-label use of medicines: Medical research and medical practice
por: Khamar, Bakulesh
Publicado: (2007)

Combined photodynamic therapy and intravitreal bevacizumab as primary treatment for subretinal neovascularization associated with type 2 idiopathic macular telangiectasia
por: Rishi, Pukhraj, et al.
Publicado: (2009)

Visual acuity and electroretinography findings 3 ½ years after the first intravitreal injection of bevacizumab (Avastin) in aggressive posterior retinopathy of prematurity
por: Shah, Parag K, et al.
Publicado: (2011)

A comparative study between intravitreal triamcinolone and bevacizumab for macular edema due to central retinal vein occlusion with poor vision
por: Gundogan, Fatih C, et al.
Publicado: (2012)

Commentary: Oral management of diabetic retinopathy
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Commentary: Diabetic retinopathy and its correlation with other diabetic complications
por: Delhiwala, Kushal, et al.
Publicado: (2021)

Commentary: Retinal pigment epithelial leak identification in central serous chorioretinopathy: Is fundus fluorescein angiography a must?
por: Delhiwala, Kushal, et al.
Publicado: (2022)

Pars plana vitrectomy versus three intravitreal injections of bevacizumab for nontractional diabetic macular edema: A prospective, randomized comparative study
por: Kucukevcilioglu, Murat, et al.
Publicado: (2015)

Dexamethasone intravitreous implant vs bevacizumab for central retinal vein occlusion‐related macular oedema: A prospective randomized comparison—Comment
por: Wen, Dejia, et al.
Publicado: (2019)

Comment on: “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
por: Tripathy, Koushik
Publicado: (2018)

Comparison of single injection of intravitreal triamcinolone versus single injection of intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusions with regard to changes in best corrected visual acuity and central macular thickness in the short term
por: Kelkar, Aditya S., et al.
Publicado: (2009)

Response to comment on “Case report of a secondary macular hole closure after intravitreal bevacizumab therapy in a patient with retinal pigment epithelial detachment”
por: Storch, Marcus, et al.
Publicado: (2018)

Intravitreal bevacizumab: an analysis of the evidence
por: Smit, Derrick P, et al.
Publicado: (2007)

Indistinct retinal outer layers in the walls of the idiopathic full-thickness macular hole - A potential predictive biomarker for surgical outcomes
por: Patel, Rushik, et al.
Publicado: (2022)

Pharmacokinetics of intravitreal bevacizumab (Avastin(®)) in rabbits
por: Sinapis, Christos I, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d2u2o5unal1hrs6usccqbhp7ru